Achaogen Stock

Achaogen Liabilities

Delisted

The The Liabilities of Achaogen (AKAOQ) as of Aug 13, 2026 is 88.58 M USD. In the previous year, The Liabilities was 75.11 M USD — a change of 17.93% (higher).

Liabilities

88.58 MUSD

YoY

17.93%

Last updated:

In 2026, Achaogen's total liabilities amounted to 88.58 M USD, a 17.93% difference from the 75.11 M USD total liabilities in the previous year.

Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Achaogen's Liabilities

Achaogen's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Achaogen's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Achaogen's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Achaogen's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Achaogen’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Achaogen stock

The Liabilities of Achaogen is 88.58 M USD in 2026.

The Liabilities of Achaogen changed from 75.11 M USD to 88.58 M USD, representing a 17.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Achaogen since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Achaogen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Achaogen

All Key Metrics — Achaogen